Clinical trial
Impact of Sodium-glucose Cotransporter 2 Inhibitors on Post-operative Atrial Fibrillation in Cardiothoracic Surgery
NCT06251453 is registered in ClinicalTrials.gov with Hamad Medical Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Sodium-glucose Cotransporter 2 Inhibitors on Post-operative Atrial Fibrillation in Cardiothoracic Surgery
- Lead sponsor
- Hamad Medical Corporation
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- October 1, 2023
- Completion date
- January 31, 2025
- Enrollment
- 3,280 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.